The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Catabolism of pyrimidines in yeast: A tool to understand degradation of anticancer drugs

På svenska

Author

  • Gorm Andersen
  • A. Merico
  • Olof Björnberg
  • Birgit Andersen
  • K. D. Schnackerz
  • D. Dobritzsch
  • Jure Piskur
  • C. Compagno

Summary, in English

The pyrimidine catabolic pathway is of crucial importance in cancer patients because it is involved in degradation of several chemotherapeutic drugs, such as 5-fluorouracil; it also is important in plants, unicellular eukaryotes, and bacteria for the degradation of pyrimidine-based biocides/antibiotics. During the last decade we have developed a yeast species, Saccharomyces kluyveri, as a model and tool to study the genes and enzymes of the pyrimidine catabolic pathway. In this report, we studied degradation of uracil and its putative degradation products in 38 yeasts and showed that this pathway was present in the ancient yeasts but was lost approximately 100 million years ago in the S. cerevisiae lineage.

Publishing year

2006

Language

English

Pages

991-996

Publication/Series

Nucleosides, Nucleotides & Nucleic Acids

Volume

25

Issue

9-11

Document type

Journal article

Publisher

Taylor & Francis

Topic

  • Biological Sciences

Keywords

  • yeast
  • uracil degradation
  • pyrimidines
  • evolution
  • cancer

Status

Published

ISBN/ISSN/Other

  • ISSN: 1525-7770